Growing community of inventors

Fort Worth, TX, United States of America

Joseph Paul Bullock

Average Co-Inventor Count = 6.46

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 16

Joseph Paul BullockMuneto Mogi (2 patents)Joseph Paul BullockWesley Wehsin Han (2 patents)Joseph Paul BullockErnesto J Castillo (2 patents)Joseph Paul BullockOnkar N Singh (2 patents)Joseph Paul BullockHaresh G Bhagat (2 patents)Joseph Paul BullockSuresh Dixit (2 patents)Joseph Paul BullockHuixiang Zhang (2 patents)Joseph Paul BullockKalliopi Stasi (2 patents)Joseph Paul BullockQuintus Medley (2 patents)Joseph Paul BullockMichela Montecchi-Palmer (2 patents)Joseph Paul BullockChinmay Maheshwari (2 patents)Joseph Paul BullockSuresh C Dixit (1 patent)Joseph Paul BullockJoseph Paul Bullock (4 patents)Muneto MogiMuneto Mogi (32 patents)Wesley Wehsin HanWesley Wehsin Han (21 patents)Ernesto J CastilloErnesto J Castillo (15 patents)Onkar N SinghOnkar N Singh (13 patents)Haresh G BhagatHaresh G Bhagat (11 patents)Suresh DixitSuresh Dixit (9 patents)Huixiang ZhangHuixiang Zhang (5 patents)Kalliopi StasiKalliopi Stasi (3 patents)Quintus MedleyQuintus Medley (3 patents)Michela Montecchi-PalmerMichela Montecchi-Palmer (3 patents)Chinmay MaheshwariChinmay Maheshwari (2 patents)Suresh C DixitSuresh C Dixit (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Alcon, Inc. (2 from 1,167 patents)

2. Novartis Ag (1 from 3,923 patents)

3. Bausch + Lomb Ireland Limited (1 from 30 patents)


4 patents:

1. 12290517 - Formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile

2. 11478480 - Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile

3. 7402609 - Olopatadine formulations for topical administration

4. 6995186 - Olopatadine formulations for topical administration

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…